Nuveen, LLC Exelixis, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 3,339,930 shares of EXEL stock, worth $133 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,339,930Holding current value
$133 Million% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
597Shares Held
257MCall Options Held
1.12MPut Options Held
1.1M-
Black Rock Inc. New York, NY33.5MShares$1.33 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.14 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$934 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$609 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$455 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $12.8B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...